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Abstract: OBJECTIVES: The purpose of this work is to present the data obtained from the first clin-
ical in vivo application of a new dedicated spiral breast computed tomography (B-CT) equipped with
a photon-counting detector. MATERIALS AND METHODS: The institutional review board approved
this retrospective study. Twelve women referred for breast cancer screening were included and underwent
bilateral spiral B-CT acquired in prone position. Additional sonography was performed in case of dense
breast tissue or any B-CT findings. In 3 women, previous mammography was available for comparison.
Soft tissue (ST) and high-resolution (HR) images were reconstructed. Two independent radiologists per-
formed separately the readout for subjective image quality and for imaging findings detection. Objective
image quality evaluation was performed in consensus and included spatial resolution, contrast resolu-
tion, signal-to-noise ratio (SNR), and contrast-to-noise ratio. All women were asked to report about
positioning comfort and overall comfort during data acquisition. RESULTS: The major pectoral muscle
was included in 15 breast CT scans (62.5%); glandular component was partially missing in 2 (8.3%) of
the 24 scanned breasts. A thin ”ring artifact” was present in all scans but had no influence on image
interpretations; no other artifacts were present. Subjective image quality assessment showed excellent
agreement between the 2 readers (฀ = 1). Three masses were depicted in B-CT and were confirmed as
simple cysts in sonography. Additional 5 simple cysts and 2 solid benign lesions were identified only
in sonography. A total of 12 calcifications were depicted with a median size of 1.1 mm (interquartile
range, 0.7-1.7 mm) on HR and 1.4 mm (interquartile range, 1.1-1.8 mm) on ST images. Median SNRgl,
SNRfat, and contrast-to-noise ratio were significantly higher in ST than in HR reconstructions (each, P
< 0.001). A mild discomfort due to positioning of the rib cage on the table was reported by 2 women
(16.7%); otherwise, no discomfort was reported. CONCLUSIONS: The new dedicated B-CT equipped
with a photon-counting detector provides high-quality images with potential for screening of breast cancer
along with minor patient discomfort.
DOI: https://doi.org/10.1097/RLI.0000000000000552





Berger, Nicole; Marcon, Magda; Saltybaeva, Natalia; Kalender, Willi A; Alkadhi, Hatem; Frauenfelder,
Thomas; Boss, Andreas (2019). Dedicated Breast Computed Tomography With a Photon-Counting
Detector: Initial Results of Clinical In Vivo Imaging. Investigative Radiology, 54(7):409-418.
DOI: https://doi.org/10.1097/RLI.0000000000000552
2
Dedicated Breast Computed Tomography With a
Photon-Counting Detector
Initial Results of Clinical In Vivo Imaging
Nicole Berger, MD,* Magda Marcon, MD,* Natalia Saltybaeva, PhD,* Willi A. Kalender, PhD,†
Hatem Alkadhi, MD, MPH, EBCR,* Thomas Frauenfelder, MD,* and Andreas Boss, MD, PhD*
Objectives: The purpose of this work is to present the data obtained from the first
clinical in vivo application of a new dedicated spiral breast computed tomography
(B-CT) equipped with a photon-counting detector.
Materials andMethods: The institutional review board approved this retrospec-
tive study. Twelve women referred for breast cancer screening were included and
underwent bilateral spiral B-CT acquired in prone position. Additional sonogra-
phy was performed in case of dense breast tissue or any B-CT findings. In 3
women, previous mammography was available for comparison. Soft tissue (ST)
and high-resolution (HR) images were reconstructed. Two independent radiolo-
gists performed separately the readout for subjective image quality and for imag-
ing findings detection. Objective image quality evaluation was performed in
consensus and included spatial resolution, contrast resolution, signal-to-noise ra-
tio (SNR), and contrast-to-noise ratio. All women were asked to report about po-
sitioning comfort and overall comfort during data acquisition.
Results: The major pectoral muscle was included in 15 breast CT scans (62.5%);
glandular component was partially missing in 2 (8.3%) of the 24 scanned breasts.
A thin “ring artifact” was present in all scans but had no influence on image in-
terpretations; no other artifacts were present. Subjective image quality assessment
showed excellent agreement between the 2 readers (κ = 1). Three masses were
depicted in B-CT and were confirmed as simple cysts in sonography. Additional
5 simple cysts and 2 solid benign lesions were identified only in sonography. A
total of 12 calcifications were depicted with a median size of 1.1 mm (interquar-
tile range, 0.7–1.7 mm) on HR and 1.4 mm (interquartile range, 1.1–1.8 mm) on
ST images. Median SNRgl, SNRfat, and contrast-to-noise ratio were significantly
higher in ST than in HR reconstructions (each, P < 0.001). Amild discomfort due
to positioning of the rib cage on the table was reported by 2 women (16.7%); oth-
erwise, no discomfort was reported.
Conclusions: The new dedicated B-CTequipped with a photon-counting detec-
tor provides high-quality images with potential for screening of breast cancer
along with minor patient discomfort.
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(Invest Radiol 2019;00: 00–00)
Two-view mammography is the standard imaging modality used forscreening and diagnosis of breast cancer, representing the only mo-
dality with proven benefits in terms of lower mortality.1–3 The main
issue of mammography is its projection-based technique, which results
in overlap of imaged structures with possible obscuration of suspicious
lesions, especially in women with dense breast.4 To ameliorate this lim-
itation, digital breast tomosynthesis has been introduced in the recent
years, showing improvements in terms of breast cancer detection.5–9
Compared with the single projection image of mammography, in digital
breast tomosynthesis, multiple low-dose projections are acquired from
different angles and subsequently used to produce stacks of image
slices, which can in part reduce the mammography overlapping effect,
however, with rather low resolution in the z-direction.10
Dedicated breast computed tomography (B-CT) systems have
been recently introduced, which can provide cross-sectional images
with high isotropic spatial resolution and better soft tissue (ST) contrast.
Breast computed tomography has the potential to further improve breast
lesion detection and characterization compared with mammography
and tomosynthesis.11–13 Previous studies investigating the use of cone
beam B-CT in comparison to mammography reported higher radiation
doses for B-CT, especially when referring to a screening setting.13,14
More recently, new strategies have strongly increased the dose effi-
ciency due to the use of novel photon-counting detector technology,
resulting in dose levels for B-CT comparable to those of screening
mammography or lower.15,16 In conventional energy-integrating detec-
tors (EIDs), the electrical signal is generated by a photodiode, which de-
tects the visible light produced by the interaction of the x-ray photons
with a scintillator material. Photo-counting detectors count individual
photons, and each count is allocated in specific energy bins related to
the photon energy, providing direct conversion of x-ray photon energy
into electric charge.17 Due to this direct conversion, photo-counting de-
tectors offer higher dose efficiency at smaller detector pixel size com-
pared with conventional EID.16,18
Additional considerations relate to the fact that both mammogra-
phy and tomosynthesis require breast compression to increase tissue
contrast and to reduce radiation dose. This can be barely tolerated by
some women or even represents the main reason for abstaining from
mammographic examination.19 In B-CT, no compression is required,
thus meeting the needs also of those women. Lastly, the possibility to
perform contrast-enhanced examinations indicates a possible usage of
B-CT comparable to breast magnetic resonance (MR) imaging with the
additional capability to simultaneously detect microcalcifications and
ST contrast enhancement.
The purpose of this study was to present the results of first clin-
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Breast computed tomography examination was offered as an alternative
to mammography to women undergoing opportunistic screening who
would have not otherwise performed the mammography because of
the pain due to the compression of the breasts. Women were admitted
to undergo B-CT examination only if they were older than 40 years and
had no mammographic examinations performed less than 12 months
prior. We included consecutive examinations performed in August
2018. Estimation of breast density on B-CT images as well as image
evaluation for lesion detection was initially performed in consensus
by 2 radiologists immediately after the B-CT data acquisition and im-
age reconstruction based on assumptions commonly applied to mam-
mography according to the American College of Radiology (ACR)
Breast Imaging Reporting and Data System (BI-RADS), fifth edition.20
Included women with dense breast or any finding in B-CT images ad-
ditionally underwent sonography, either using hand-held ultrasound or
applying an automated breast ultrasound system (ABUS). In all women
with previous mammography examinations, B-CT images were com-
pared with previous mammograms. In all cases undergoing additional
sonography, findings were noted and compared with previous sono-
graphic examinations when available.
Technical support of the vendor was available; however, the eval-
uation of patient data and the integrity of the study were completely un-
der the control of the first and last authors.
Dedicated Breast CT System
Examinations were performed placing the woman in a prone po-
sition on a dedicated spiral B-CT system (nu:view; AB-CT [Advanced
Breast CT] GmbH, Erlangen, Germany). The examination table has a
horizontal CT gantry optimized for breast imaging, which allows the
examination of one breast at a time while the other breast and the rest
of the body are not exposed. The examined breast was positioned in a
table aperture without compression (Fig. 1). The ipsilateral arm was
placed alongside the body, and the contralateral armwas elevated above
the head. All participants were instructed to breath regularly during the
scanning to minimize the possibility of movement artifacts.
The photon-counting detector uses cadmium telluride crystals
with a detector pixel size of (0.1 mm)2 and a total detector area of
280 50 mm2. The maximum possible volume to examine has a diam-
eter of 190 mm; the scanned length can be chosen at 3 different levels
(80, 120, and 160 mm) depending on the anteroposterior breast diameter.
Depending on the specified scan length, the x-ray tube loading time is
automatically adjusted. The x-ray tube has a 0.3-mm focal spot size and
3-mm Al filtration. A fixed x-ray tube voltage of 60 kV is used to
achieve sufficient contrast for visualization of microcalcifications. Data
acquisition can be performed by choosing between 2 modes: in the first
so-called “HighRes” acquisition mode, the entire breast volume can be
scanned up to 2 times within a predetermined time and the highest pos-
sible spatial resolution is achieved; in the second so-called “standard”
acquisition mode, the entire breast volume can be scanned up to 4 con-
secutive times allowing for dynamic measurements over the time (eg,
after contrast agent injection). In the “standard” acquisition mode, the
number of projections is inferior compared with “HighRes,” and this
makes possible the acquisition of consecutive image datasets without
interruption necessary for data transmission. The tube current can be
varied between 5 and 125 mA. Additional parameters are reported in
Table 1. All examinations were performed using the “HighRes” acqui-
sition mode considering the screening purpose of the B-CT performed
in our study. Moreover, based on preliminary studies, all examinations
were performed with a tube current of 25 mAwith the aim to keep ra-
diation dose at similar level to screening mammography.15,16 For image
reconstructions, a Feldkamp-type filtered back-projection algorithm
was used by the nu:view reconstruction software. A smooth kernel
(300 μm3) voxel size and 4 4 detector binning were used for ST image
reconstruction. A Shepp-Logan kernel of (150 μm)3 voxel sizewith 2 2
detector binning was used for high-resolution (HR) image reconstruction
applied for detection and characterization of microcalcifications.
Image Evaluations
Raw image datawere reconstructed to 0.3-mm axial slices for ST
evaluation (ST reconstruction, ST) and to 0.15-mm axial slices for eval-
uation of microcalcifications (HR reconstruction, HR). Image analysis
was performed on a PACSworkstation equippedwith a dedicated breast
imaging display software (AGFA Impax 6, Mortsel, Belgium) and the
possibility to obtain additional sagittal and coronal reformations as well
as maximum intensity projection (MIP) reformations with a slice thick-
ness of up to 50 mm.
Subjective Image Quality and Imaging Findings Detection
Subjective image quality evaluation was independently performed
by 2 radiologists with 7 years of experience in breast imaging (N.B., M.M.).
Each reader in one reading session evaluated all cases. Reformations in the
sagittal and coronal plane and corresponding MIP images were initially
rated, taking into account the criteria normally applied to mammography
according to the PGMI (perfect, good, moderate, inadequate) evaluation
system.21 Accordingly, the following criteria for image quality assess-
ment were applied: (a) complete inclusion of the breast tissue (including
complete inclusion of the glandular tissue, Chassaignac bursa, and most
superficial part of the pectoralis major muscle); (b) presence/
TABLE 1. B-CT Parameters
X-ray tube current 5–125 mA “HighRes”; 5–64 mA “Standard”
X-ray tube voltage 60 kV
Data acquisition rate Up to 1000 Hz
No. projections Up to 2000 per 360 degrees
No. reconstruction images* ST, 313–589; HR, 626–1178
Reconstruction field of
measurement
200  80–160 mm
Acquisition time* 7–12 s/scan
*Depending on the scan length.
ST indicates soft tissue reconstruction; HR, high-resolution reconstruction.
FIGURE 1. The examination table has a horizontal CT gantry, and the
examined breast is placed in a table aperture in a plastic cylinder
without compression. The maximum possible breast volume to examine
has a diameter of 190mm and a height of 160mm. Scan length can be
adjusted at 3 different levels (80, 120, and 160 mm) depending on the
anteroposterior breast diameter.
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absence of subject-related motion artifacts; (c) presence/absence of
system-related artifacts (eg, “ring” artifact; beam-hardening artifact);
and (d) symmetrical representation of the 2 breasts, as evaluated in
the MIP images in sagittal and coronal reformations, mimicking the
mediolateral oblique and craniocaudal mammographic view, respec-
tively. In presence of artifacts, the readers had to indicate whether these
were interfering with image interpretation.
The visibility and demarcation of the following breast structures
were evaluated in STandHR aswell as inmammography according to a
5-point Likert scale (1 and 5 corresponding to the lowest and highest
visibility and demarcation, respectively): skin-air boundary, glandular
tissue, fat tissue, and Cooper ligaments.
Moreover, each reader recorded B-CT imaging findings by
reporting category (mass, calcification, architectural distortion) and lo-
cation (side and quadrant) of the lesion. The final reports issued in con-
sensus during the first B-CT dataset evaluation together with the
sonographic assessment in case of dense breast or any B-CT finding
were used as reference standard.
Objective Image Quality
For each examination, objective image quality measurements
were performed in consensus by the 2 readers. Calcifications were mea-
sured in mammography and in ST and HR reconstructions as surrogate
for the assessment of spatial resolution. For signal and contrast evalua-
tion, an arbitrary defined, circular 1.3 1.3 cm region of interest (ROI)
was placed in the glandular tissue, in fat tissue, and in the background
air. To measure the signal-to-noise ratio (SNR) of the glandular and
fat component of the breast, the average attenuation value separately
measured in the tissue components (Sgl and Sfat, respectively) was divided
by the standard deviation in the background (SDair) for both reconstruc-
tion methods. Signal values were referenced to measurements in air (de-
fined as zero signal). The contrast-to-noise ratio (CNR) was evaluated as
the difference between Sgl and Sfat divided by SDair. The ROIs were cop-
ied manually to the same location in ST and HR reconstructions.
Dose Estimation
The radiation dose was evaluated by Monte Carlo (MC) simula-
tions using a commercially available tool (ImpactMC; AB-CT GmbH,
Erlangen, Germany). At the first step, theMC toolwas validated against
the measurements using a standard CT dose index (CTDI) phantom
with a diameter of 16 cm and a 10-cm long ionization chamber. The
phantom was placed at the isocenter of the breast CT scanner, and the
dose values were measured at the central and peripheral positions of
the phantom using the protocols summarized in Table 2. In addition,
CTDI values free in air were measured for further conversion of the sim-









where CTDIc and CTDIp are the dose integrals measured by the ioniza-
tion chamber at the center and at the peripheral positions of the 16-cm
CTDI phantom, respectively. Then, measured values were compared
with the simulated ones, and the relative difference between simulated







After the validation procedure, the MC simulations were performed in
cylindrical phantoms of various diameters, starting from 80 mm up to
200 mm, in a step of 20 mm. The material composition was defined
as a mixture of 80% and 20% of adipose and glandular tissue, respec-
tively. The kVp and mAs settings for the MC simulations were selected
to be equal to those used for the patients' image acquisitions. Simula-
tions were performed using a graphics processing unit cluster with the
number of simulated histories set to 2  109 to ensure statistically ac-
ceptable levels of uncertainty (<1%). The average dose absorbed by
each cylinder was calculated based on the 3-dimensional dose distribu-
tion obtained from the MC simulations. Then, the patient-specific
breast diameter was measured using the B-CT datasets in the middle
of the acquired volume, and the radiation dose absorbed by the patient's
breast was determined based on MC simulations on the cylindrical
phantom with the corresponding diameter.
Comfort Assessment
After the B-CT examination, all women were asked to report
about their experience during the scan and in particular to rate the com-
fort of the position and their overall comfort level during the examina-
tion on a scale from 1 to 5 (with 5 indicating maximal comfort). In
women with previous mammography examinations, a comparison in
terms of comfort was also requested (higher, equal, or lower).
Statistical Analysis
The Shapiro-Wilk test showed nonnormal distribution of the
data. Descriptive data are provided as median and interquartile range
(IQR). Cohen κ coefficient was used to evaluate interobserver agree-
ment between the 2 readers who performed the subjective image quality
analysis and categorization of B-CT findings. Bland-Altman plots were
used to represent the size differences of microcalcifications measured in
mammography and with STand HR B-CT reconstructions. TheWilcoxon
signed rank test was used to compare microcalcification measurements
performed in mammography and with ST and HR, glandular tissue
SNR (SNRgl), fat tissue SNR (SNRfat), and CNR in the ST and HR.
The Bonferroni correction was used to correct for multiple comparison,
and a 2-sided P value of less than 0.017 (0.05/3) was considered statis-
tically significant. Statistical analyses were performed with commer-
cially available software (SPSS, release 22.0; SPSS Inc, Chicago, IL).
RESULTS
Subject Characteristics
Twelve women (median age, 52.5 years; IQR, 48.7–54 years)
were included, and all of them underwent bilateral B-CT. Five women
had a previous mammography.Mammography and sonographic images
from previous examinations were available in 3 cases performed 18, 24,
and 36 months before B-CT; in 2 additional cases, previous mammog-
raphy was not performed in our hospital and images were not available.
American College of Radiology breast density categories were as fol-
lows: 2 cases A (16.7%), 2 cases B (16.7%), 5 cases C (41.6%), and
3 cases D (25%). All cases C and D underwent additional sonography.
In cases ACR A and B, the 2 radiologists evaluating in consensus the
images were confident to exclude the presence of any lesion due to
the lack of dense tissue components or any additional finding that could
have masked subtle lesions.
TABLE 2. Summary of the B-CT Protocol Parameters Used for the
MC Code Validation
Parameter Value
Tube voltage, kVp 60
Tube current, mA 5, 50, 125
B-CT indicates breast computed tomography; MC, Monte Carlo; kVp,
kilovoltage peak.
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Image Evaluations
Subjective Image Quality
Results from image quality assessment are reported in Table 3.
Cohen κ showed excellent agreement (κ = 1) between the 2 readers
for the image quality assessment and artifact identification. In the total
of 24 scanned breasts, the pectoralis major muscle was not included in 9
cases (37.5%) and the external glandular component was not bilaterally
included in one (8.3%). In the latter case, the external glandular compo-
nent was also not included in the previous mammographic examination.
None of the B-CT cases exhibited movement artifacts. A “ring artifact,”
consisting of a thin black circular line in consecutive axial images, was
constantly present. The ring artifact was more pronounced in HR recon-
structions (Fig. 2) compared with ST. In all cases, this artifact had no ef-
fect on image interpretation. No beam-hardening artifacts were present.
Scores assigned to visibility and demarcation of breast structures
in ST, HR, and mammography are reported in Table 4. Excellent agree-
ment was found (κ = 1) between the 2 readers for all structures in
mammography and for all skin-air boundary evaluations but poor to fair
agreement for all other investigated features (κ = 0.12–0.53). Neverthe-
less, a very high score4,5was assigned by the 2 readers in all cases to the
glandular and fat tissue demarcation and in all but one case (score 3 by
both readers in SR and HR reconstruction) to the representation of the
fibrous structures constituting the Cooper ligaments. Both readers
assigned a score of 3 to 2/3 cases and a score of 4 to 1/3 cases for glan-
dular and fat tissue demarcation and a score of 3 to 3/3 cases for
Cooper ligaments.
Breast Imaging Findings
In 1 woman, 2 oval circumscribed masses were identified on
B-CT images in one breast (maximum diameter, 15 mm and 11 mm)
that corresponded to simple cysts on ABUS (16 mm and 10 mm, re-
spectively; Fig. 3). In the same woman, 3 additional simple cysts were
depicted only on ABUS (maximum diameter median, 8 mm; range,
6–12 mm). All these cysts were stable compared with a previous















n R1 R2 R1 R2 R1 R2 R1 R2 R1 R2 R1 R2 R1 R2 R1 R2
1 MP MP MP MP A A RA RA RA RA Yes Yes 1 1 M M
2 Yes Yes MP MP A A RA RA RA RA Yes Yes No No No No
3 GlT GlT GlT GlT A A RA RA RA RA Yes Yes No No No No
4 MP MP MP MP A A RA RA RA RA Yes Yes No No No No
5 Yes Yes MP MP A A RA RA RA RA Yes Yes 1 1 No No
6 Yes Yes Yes Yes A A RA RA RA RA Yes Yes 1 1 No No
7 Yes Yes Yes Yes A A RA RA RA RA Yes Yes No No No No
8 MP MP MP MP A A RA RA RA RA Yes Yes No No No No
9 Yes Yes Yes Yes A A RA RA RA RA Yes Yes No 1 No No
10 Yes Yes Yes Yes A A RA RA RA RA Yes Yes 4 3 No No
11 Yes Yes MP MP A A RA RA RA RA Yes Yes 1 1 No No
12 Yes Yes Yes Yes A A RA RA RA RA Yes Yes 3 3 M M
B-CT indicates breast computed tomography; AD, architectural distortion; R1, reader 1; R2, reader 2; MP, pectoralis major muscle not included; GlT, part of the
glandular tissue not completed included at level of the axillary tale; A, absent; RA, ring artifact; M, mass.
FIGURE 2. Ring artifact in a B-CT image. The artifact is more prominent on HR (A) as opposed to ST (B), however, did not impair image evaluation.
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sonographic examination and were not visible in previous mammo-
grams. In another woman, an oval circumscribed mass was identified
on B-CT images (6 mm), which corresponded on ABUS to a
circumscribed benign solid lesion (6 mm). Calcifications were depicted
in 7/12 cases (58.3%), which were single and unilateral in 5 cases (5/7,
71.4%) and multiple and/or bilateral in other 4 cases (2/7, 28.6%) for a
total of 12 calcifications. In 2 cases, previous mammography was avail-
able for comparison and calcifications were classified as stable in both
cases. In all cases, calcifications had no suspicious distribution. No
cases of architectural distortion were observed.
Both readers identified 11/12 (91.7%) calcifications and 3/3
(100%) masses on B-CT images and Cohen κ showed moderate
(κ = 0.73) and excellent (κ = 1) agreement, respectively. Among the
women undergoing additional hand-held ultrasound, in one case, a sim-
ple cystic lesion (4 mm) and a circumscribed solid lesion (10 mm) were
additionally depicted. Similarly, in another case, a simple cyst (3 mm)
and a circumscribed solid lesion (6 mm) were additionally found.
Objective Image Quality
Among the total of 12 calcifications comparison with previous
mammograms was possible for 5 calcifications (Figs. 4, 5). Median
calcification size on mammography, HR, and STwas 0.6 mm (IQR,
0.5–0.9 mm), 1.1 mm (IQR, 0.7–1.7 mm), and 1.4 mm (IQR,
1.1–1.8 mm), respectively, with significant difference between the mea-
surements performed on HR and ST images (P = 0.006) but not be-
tween mammography versus HR and ST (P = 0.102 and P = 0.042,
respectively). The Bland-Altman plots referring to the calcification size
differences measured in mammography, ST, and HR reconstructions
are shown in Figure 6.
Signal-to-noise ratio and CNR values in ST and HR recon-
structions are reported in Table 5. In 2 women with an ACR density
of A, glandular tissue representation was insufficient to perform ROI
measurements, and SNRgl and CNR were not evaluated. Median
SNRgl, SNRfat, and CNR were significantly higher in ST than in HR
reconstructions (P < 0.0001).
Dose Estimation
The differences between measured and simulated CTDIw values
(∆CTDI) are shown in Table 6. The maximum deviation of the
simulated to the measured dose was 4.4% at 50 mA, whereas the aver-
age absolute difference between measurements and simulations was
within 3.6%. The mean dose obtained from MC simulations was
5.08 mGy (range, 4.4–5.7 mGy).
Comfort Assessment
All women included in the study were in a good physical condi-
tion (ie, no reported mobility restrictions in daily activity) and could get
on and off the examination table without assistance. Position comfort
was rated 3 in 2 cases (16.7%), 4 in 9 cases (75%), and 5 in 1 case
(8.3%), and overall comfort was rated in 10 cases, 4 (83.3%), and in
2 cases, 5 (16.7%). All women with a previous mammographic exami-
nation reported a higher comfort for B-CT, attributed to the absence of
breast compression in B-CT. The only complaints concerned a mild dis-
comfort due to the position of the rib cage resting on the table at the
margin of the gantry reported by 2 women (16.7%).
DISCUSSION
This study presents the first data obtained from the clinical in vivo
application of a new dedicated spiral-B-CTusing a photon-counting detec-
tor. Breast computed tomography is a cross-sectional imaging technique
with a proven higher diagnostic accuracy compared with mammography
regarding breast lesions.11–13 The higher accuracy results from the largely
resolved overlapping of the breast tissue and the possibility to analyze im-
aging findings inmultiple anatomical planes from a single scan. Up to now,
resolution of B-CT did not reach high enough resolution to visualize
microcalcifications, which the new dedicated B-CT can provide. A previ-
ous experimental study has been conducted using the same system and
included the evaluation of surgical specimens. In this previous study, it
has been demonstrated that the system can achieve a spatial isotropic res-
olution of better than 5 line pairs/mm corresponding to better than
100 μm resolution, with low noise level and under the maximal permitted
level of dose exposition.15 The high resolution, but also the possibility to
evaluate the images in different planes, increases and facilitates the
characterization of lesions regarding suspicious features such as conspi-
cuity, calcifications, and asymmetries, as well as masses.14,22,23
Due to the retrospective nature of our study, no mammography
was performed in addition to B-CT, and previous mammography was
available only in a limited number of cases, thus precluding a systematic
TABLE 4. Visibility and Demarcation of Breast Structures in ST and HR Reconstructions as well as Mammography Evaluated According to a
5-Point Likert Scale (1, Lowest Visibility and Demarcation; 5, Highest Visibility and Demarcation)
Skin-Air Boundary Glandular Tissue Fat Tissue Cooper Ligaments
ST HR Mx ST HR Mx ST HR Mx ST HR Mx
n R1 R2 R1 R2 R1 R2 R1 R2 R1 R2 R1 R2 R1 R2 R1 R2 R1 R2 R1 R2 R1 R2 R1 R2
1 5 5 5 5 5 5 4 4 4 4 3 3 4 5 4 5 3 3 4 4 4 4 3 3
2 5 5 5 5 NM NM 4 4 5 5 NM NM 5 5 4 5 NM NM 5 4 4 4 NM NM
3 5 5 5 5 5 5 4 4 5 5 4 4 4 4 4 4 4 4 5 5 4 4 3 3
4 5 5 5 5 NM NM 4 5 4 5 NM NM 4 5 4 5 NM NM 3 3 3 3 NM NM
5 5 5 5 5 NM NM 4 5 4 5 NM NM 4 5 4 5 NM NM 4 4 4 4 NM NM
6 5 5 5 5 NM NM 4 4 4 4 NM NM 4 4 4 4 NM NM 4 5 4 5 NM NM
7 5 5 5 5 NM NM 5 5 5 5 NM NM 5 5 4 5 NM NM 4 4 4 4 NM NM
8 5 5 5 5 NM NM 4 4 4 4 NM NM 4 4 4 4 NM NM 5 5 4 5 NM NM
9 5 5 5 5 NM NM 5 5 5 5 NM NM 5 5 5 5 NM NM 4 4 4 4 NM NM
10 5 5 5 5 5 5 4 5 4 5 3 3 4 5 4 5 4 4 4 4 4 4 3 3
11 5 5 5 5 NM NM 4 4 4 4 NM NM 4 4 4 4 NM NM 4 5 4 5 NM NM
12 5 5 5 5 NM NM 4 4 4 4 NM NM 4 4 4 4 NM NM 4 4 4 4 NM NM
1 1 1 0.44 0.53 1 0.38 0.12 1 0.52 0.34 1
ST indicates soft tissue reconstruction; HR, high-resolution reconstruction; R1, reader 1; R2, reader 2; Mx, mammography; NM, no mammography available.
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comparison. Nevertheless, our initial data demonstrate a high B-CT per-
formance in terms of image quality. Visibility and demarcation of breast
structures were in general excellent in B-CTwith a slightly better per-
formance of the ST reconstruction compared with HR, which is sup-
ported by the higher SNR and CNR values. On the other hand, HR
outperformed ST reconstruction for determining calcification sizes,
with values being similar to those from mammography. Discrepancy
in size measurements of calcifications in different reconstruction al-
gorithms in CT is known due to blooming artifacts.24 In our study, the
smallest identified calcification in B-CT as well as in mammography
was 0.4 mm. There were no smaller calcifications in B-CTor the avail-
able mammograms to verify the size limit of the detection of even
smaller calcifications. Further studies are necessary to perform an accu-
rate comparison of calcification size in B-CT and mammography to
demonstrate also in vivo that calcification down to 0.1 to 0.2 mm can
be identified similar to mammography. Indeed, digital mammography
has a spatial resolution of 5 to 9.3 line pairs/mm, whereas previous stud-
ies investigating the use of cone beamB-CT have shown that a maximum
of 2.6 line pairs/mm can be achieved, ensuring depiction of calcifications
down to 0.2 to 0.3 mm.14,25 In B-CT, higher-contrast resolution can be
FIGURE 3. Oval circumscribed lesion at 11 to 12 o'clock in the left breast of a 51-year-oldwoman. The lesion can be easily depicted in the coronal, sagittal,
and axial B-CT ST (A–C). The corresponding lesion in coronal and axial ABUS images (D)was a cyst with amaximumdiameter of 11mm that was stable
compared with a previous sonographic examination performed 18 months before B-CT. Two additional cysts can be recognized in the coronal ABUS
image at 11 and 2 o'clock closer to the nipple (marked with asterisk). Although we consider that some breast density changes could be occurred in the
time interval, in mammography (E and F) performed 18 months before B-CT, the cyst was not clearly identifiable.
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FIGURE 4. A 57-year-old woman with known microcalcification and macrocalcification of the breast. A macrocalcification is visible in the mediolateral
oblique mammogram in the central retroareolar region andmagnification is provided (A). Mammography was performed 24months before B-CT. HR
(B) and ST (C) and corresponding magnification of the macrocalcification are provided. Although the 2 examinations were performed in a long time
interval and variation of calcification size cannot be excluded, similar values of maximal diameter were measured. Concerning B-CT images, almost
identical values could be measured in the images obtained with both HR and ST.
FIGURE 5. Same woman as in Figure 2. A microcalcification is visible in the mediolateral oblique mammogram in the retroareolar region and
magnification is provided (A). Mammography was performed 24 months before B-CT. HR (B) and ST (C) and corresponding magnification of the
microcalcification are provided. In HR magnification, additional microcalcifications can be recognized (white arrows). Although the 2 examinations
were performed in a long time-interval and variation of calcification size could have occurred, similar values of minimum diameter were measured in
mammogram and HR. In ST, the minimum diameter was 0.3 mm larger than in HR.
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exploited to compensate for the lower spatial resolution. A reasonable
approach could combine the evaluation of ST reconstructed images,
with their higher CNR to facilitate calcification depiction, followed by
a more accurate characterization of calcifications on HR images.
The possibility to obtain sagittal and axial reconstructions as well
as MIP reconstructions, simulating MLO and CC projection, respectively,
can facilitate and fasten image interpretation. Depiction of the most
superficial part of the pectoralis major muscle is desirable as a quality
criterion in B-CT scans. Sporadic lack of the pectoralis muscle in the
initial CT scans was optimized by improved patient positioning on
the scanner table. In only one case, parts of the glandular tissue at axil-
lary tail level were not included in the acquired volume. In this case, the
same was also observed in the previous mammography. Nevertheless,
the positioning of the patient has to be carefully done by the technician
to obtain the optimal coverage and to include as much external glandu-
lar component as possible. Limited coverage of axilla and axillary tail
compared with mammography is a known limitation of B-CT.14,26
However, enlarged lymph nodes on otherwise normal mammograms
are rarely malignant and clinically significant, and their noninclusion
in B-CT images can be considered of negligible clinical value. A com-
prehensive evaluation of the breast glandular tissue needs to be guaran-
teed also in women with glandular extension in the axillary tail area by
integrating B-CT images with a sonographic evaluation.27,28Moreover,
additional sonography remains crucial in all women with dense breasts.13
Indeed, among our records, additional cystic lesions up to 10 mm,
completely surrounded by glandular tissue, were not visible in B-CT im-
ages an only depicted in sonography due to a lack of a “mass-effect.”Due
to the presence of a single solid lesion in our series, we could not inves-
tigate the diagnostic performance of B-CT for solid versus cystic le-
sions and also this aspect will be better explored in upcoming studies.
Although we are aware that the high efficacy of screening with
mammography on reducing breast cancer mortality relies on the use
of standardized protocols with proved high safety and reproducibility
and that the implementation of a B-CT in this setting would require
an extensive evaluation in a prospective clinical trial, an important im-
mediate advantage of B-CT is that women who previously avoided
screening examinations or diagnostic mammograms due to painful
compression of their breast can now be motivated to be examined.29–31
Moreover, due to the advantage of a cross-sectional imaging technique,
more information is provided within one single examination, avoiding
for example further examinations such as an additional tomosynthesis
after an inconclusive mammography. Similar to other studies12,14,23
having the limitation that all included women were in good physical
condition, no significant discomfort during B-CTwas reported.
The possibility to apply contrast media on B-CT represents an-
other potential advantage, and this could be an alternative to breast
MR imaging in patients otherwise not eligible because of hypersensitiv-
ity to contrast media, claustrophobia, or other contraindications to
breast MR imaging.22,32,33
Usually, in cone-beam B-CT, 2 orthogonal low-dose scout im-
ages are initially acquired to set the optimal tube current and achieve
the best compromise between dose and contrast-to-noise ratio
(CNR).14 Due to the design of the spiral B-CT acquisition, a scout im-
age is not available and scan parameters need to be defined before data
acquisition. In our study, we used a constant tube current of 25 mA and
tube voltage of 60 kVacross all examinations, resulting in a dose com-
parable to a conventional screening mammography.15,16 A homoge-
neous dose distribution in the breast is a known additional advantage
of B-CT compared with mammography.11Moreover, the photo-counting
technology should allow a further dose reduction due to the higher ef-
ficiency of x-ray photon energy conversion into electric charge.16Nev-
ertheless, to obtain adequate image quality at the lowest possible dose,
further studies are mandatory to investigate the optimal tube current and
tube voltage levels depending on the respective clinical indication,
breast size, and breast composition. Such investigations may potentially
be performed in patients with a high likelihood of radiation therapy or
mastectomy (BIRADS 5 and 6 lesions).
The “ring artifact” is a known artifact in CT imaging typically
due to malfunction or miscalibration of one or more detectors.34 Al-
though considering the small number of cases included, that limits de-
finitive conclusions, in our study, similar to a previous study by
O'Connell et al,14 the presence of this artifact did not interfere with
FIGURE 6. Bland-Altman plot comparing calcification measurements
performed onmammography versus HR (A), mammography versus ST
(B), and HR versus ST (C). The horizontal lines represent the mean and
95% confidence intervals. Black dots represent calcifications smaller
than 0.5 mm as measured on at least one among mammography,
HR and ST images.
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image interpretation. Even considering the possibility that a singular
microcalcification could be shadowed by the artifact, it would not
have any clinical consequence. Moreover, the artifact appearance
does not reproduce any known microcalcification distribution pat-
tern, thus minimizing the possibility to miss clinically significant
microcalcifications even in case that one of them is shadowed by
the artifact. In addition, we found no motion artifacts in our image
data sets. None of the women presented a breast tissuemarker to allow
for comparison in terms of beam-hardening artifacts. A previous phan-
tom study showed a significant effect of breast markers on image qual-
ity, and this factor should be considered when women with previous
breast interventions undergo B-CT.35
As the images are cross-sectional and can be evaluated using dif-
ferent planes, a longer reading time compared with mammograms is
foreseeable. Nevertheless, optimization of image reconstruction has
the potential to assist the radiologist for the depiction and characteriza-
tion of breast lesions to expedite the reading process.
Our study has several limitations including the small number of
retrospective cases and, as mentioned preciously, the lack of a parallel
mammography for direct comparison. In the few cases with availability
of a previous mammography, the mammography was performed a rather
long time before the B-CT, thus limiting a rigorous comparison. Also,
none of the patients had amalignant lesion. Nevertheless, our work aimed
at a presentation of the first in vivo images obtained with a new approved
and commercially available B-CT system and to show its diagnostic po-
tential. In addition, related to the lack of parallel mammography, the
lack of comparison in dose estimation between mammography and
B-CT has to be addressed. A systematic comparison of dose estimation
as well as diagnostic accuracy for the 2 imaging modalities will be the
goal of upcoming prospective studies.
In conclusion, the new dedicated spiral B-CT equipped with a
photon-counting detector provides high-quality images at low radiation
dose and shows considerable potential for screening and diagnosis of
breast cancer, along with improved patient comfort compared with
conventional mammography.
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